Terms: = Bone cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Staging
4 results:
1. DSP30 and interleukin-2 as a mitotic stimulant in B-cell disorders including those with a low disease burden.
Dun KA; Riley LA; Diano G; Adams LB; Chiu E; Sharma A
Genes Chromosomes Cancer; 2018 May; 57(5):260-267. PubMed ID: 29349871
[TBL] [Abstract] [Full Text] [Related]
2. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
[TBL] [Abstract] [Full Text] [Related]
3. Elevated soluble il-2 receptor levels correlate with tumor bulk of follicular lymphomas with intestinal involvement.
Iwamuro M; Shinagawa K; Okada H; Takata K; Yoshino T; Yamamoto K
Clin Biochem; 2014 Feb; 47(3):191-5. PubMed ID: 24362271
[TBL] [Abstract] [Full Text] [Related]
4. Management of chronic lymphocytic leukemia.
Han T; Rai KR
Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
[TBL] [Abstract] [Full Text] [Related]
